Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001177601 | SCV001341838 | likely benign | Familial hypercholesterolemia | 2019-01-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001177601 | SCV001700381 | likely benign | Familial hypercholesterolemia | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003372903 | SCV004098398 | uncertain significance | Cardiovascular phenotype | 2023-06-23 | criteria provided, single submitter | clinical testing | The c.2397C>T variant (also known as p.L799L), located in coding exon 17 of the LDLR gene, results from a C to T substitution at nucleotide position 2397. This nucleotide substitution does not change the leucine at codon 799. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may result in the creation or strengthening of a novel splice acceptor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003480889 | SCV004224562 | uncertain significance | not provided | 2022-05-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003103 | SCV004820680 | likely benign | Hypercholesterolemia, familial, 1 | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001177601 | SCV002086878 | likely benign | Familial hypercholesterolemia | 2020-03-09 | no assertion criteria provided | clinical testing |